Literature DB >> 3542942

A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients.

S W Newsom, P Murphy, J Matthews.   

Abstract

A prospective, comparative clinical trial of ciprofloxacin (100 mg bd) versus trimethoprim (200 mg bd), both for five days, was carried out in 40 geriatric patients with urinary tract infection. Thirty-two could be assessed for drug efficacy, and all forty for toxicity studies. Both drugs were equally safe, and ciprofloxacin was at least as effective as trimethoprim as far as clinical response was concerned. Ciprofloxacin appeared more effective in eradication of bacteria. Antibacterial activity was found in urine and faeces up to five days after stopping ciprofloxacin therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542942     DOI: 10.1093/jac/18.supplement_d.111

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  Treatment of urinary infection in the elderly.

Authors:  M G Morgan; W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

Review 2.  Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 3.  Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review.

Authors:  H van Poppel; V Chyský; R Hullmann; L Baert
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 4.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 5.  Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly.

Authors:  L R Wiseman; J A Balfour
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

6.  Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial.

Authors:  Thomas Vogel; René Verreault; Marie Gourdeau; Michèle Morin; Lise Grenier-Gosselin; Louis Rochette
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

7.  Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.

Authors:  T J Louie
Journal:  CMAJ       Date:  1994-03-01       Impact factor: 8.262

Review 8.  Worldwide clinical data on efficacy and safety of ciprofloxacin.

Authors:  P Schacht; G Arcieri; J Branolte; H Bruck; V Chyský; E Griffith; G Gruenwaldt; R Hullmann; C A Konopka; B O'Brien
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 9.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 10.  The use of oral fluoroquinolones in nursing home patients.

Authors:  T M File; J S Tan
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.